Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study.
Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study.
复制标题
DOI:
10.1016/j.jacc.2008.11.051
复制
发表时间:
2009-03-31
影响因子:
24
通讯作者:
Redfield, Margaret M.
中科院分区:
文献类型:
--
作者:
Lam, Carolyn S. P.;Roger, Veronique L.;Rodeheffer, Richard J.;Borlaug, Barry A.;Enders, Felicity T.;Redfield, Margaret M.
To define the prevalence, severity and significance of pulmonary hypertension (PH) in heart failure with preserved ejection fraction (HFpEF) in the general community. While HFpEF is known to cause PH, its development is highly variable. Population-based data are lacking, and the relative contribution of pulmonary venous versus pulmonary arterial hypertension to PH in HFpEF is unknown. We hypothesized that PH would be a marker of symptomatic pulmonary congestion, distinguishing HFpEF from preclinical hypertensive heart disease (HTN). Population-based study of 244 HFpEF patients (76±13y; 45%male) followed from Doppler echocardiography over 3 years. Controls were 719 adults with HTN without HF (66±10y; 44%male). Pulmonary artery systolic pressure (PASP) was derived from the tricuspid regurgitation velocity and PH defined as PASP>35 mmHg. Pulmonary capillary wedge pressure (PCWP) was estimated from E/e’. In HFpEF, PH was present in 83% and median (25th, 75th percentile) PASP was 48 (37, 56) mmHg. PASP increased with PCWP (r=0.21; p<0.007). Adjusting for PCWP, PASP was higher in HFpEF than HTN (p<0.001). PASP distinguished HFpEF from HTN with an area under receiver-operating curve of 0.91 (p<0.001) and strongly predicted mortality in HFpEF (hazard ratio=1.3 per 10 mmHg; p<0.001). PH is highly prevalent and often severe in HFpEF. While pulmonary venous hypertension contributes to PH, it does not fully account for the severity of PH in HFpEF, suggesting that a component of pulmonary arterial hypertension also contributes. The potent effect of PASP on mortality lends support for therapies aimed at pulmonary arterial hypertension in HFpEF.
登录
查看更多内容
影响因子:
37.8
作者:
Moraes, DL;Colucci, WS;Givertz, MM
通讯作者:
Givertz, MM
影响因子:
168.9
作者:
Anand, I;McMurray, J;Lüscher, TF
通讯作者:
Lüscher, TF
影响因子:
120.7
作者:
Redfield, MM;Jacobsen, SJ;Rodeheffer, RJ
通讯作者:
Rodeheffer, RJ
影响因子:
37.8
作者:
Borlaug, BA;Melenovsky, V;Kass, DA
通讯作者:
Kass, DA
影响因子:
24
作者:
Klapholz, M;Maurer, M;Le Jemtel, TH
通讯作者:
Le Jemtel, TH